Audience: Patient, OBGYN, Oncology ISSUE: The FDA is alerting women about the risks associated with the use of tests being marketed as ovarian cancer screening tests. The Agency is especially concerned about delaying effective preventive treatments…
Ovarian Cancer Screening Tests: Safety Communication – FDA Recommends Against Use
- October 24, 2016
